Viscoelasticity of hyaluronic acid‐gelatin hydrogels for vocal fold tissue engineering. Issue 2 (27th February 2015)

• Record Type: Journal Article
• Authors: Kazemirad, Siavash; Heris, Hossein K.; Mongeau, Luc
• Is Part Of: Journal of biomedical materials research. Volume 104:Issue 2(2016:Feb.)
• Page Start: 283
• Page End: 290
• Publication Date: 2015-02-27
• Subjects: viscoelastic properties -- hyaluronan hydrogels -- vocal folds -- injectable biomaterials -- wave propagation method; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.b.33358
• Languages: English
• ISSNs: 1552-4973

Abstract

Abstract: Crosslinked injectable hyaluronic acid (HA)‐gelatin (Ge) hydrogels have remarkable viscoelastic and biological properties for vocal fold tissue engineering. Patient‐specific tuning of the viscoelastic properties of this injectable biomaterial could improve tissue regeneration. The frequency‐dependent viscoelasticity of crosslinked HA‐Ge hydrogels was measured as a function of the concentration of HA, Ge, and crosslinker. Synthetic extracellular matrix hydrogels were fabricated using thiol‐modified HA and Ge, and crosslinked by poly(ethylene glycol) diacrylate. A recently developed characterization method based on Rayleigh wave propagation was used to quantify the frequency‐dependent viscoelastic properties of these hydrogels, including shear storage and loss moduli, over a broad frequency range; that is, from 40 to 4000 Hz. The viscoelastic properties of the hydrogels increased with frequency. The storage and loss moduli values and the rate of increase with frequency varied with the concentrations of the constituents. The range of the viscoelastic properties of the hydrogels was within that of human vocal fold tissue obtained from in vivo and ex vivo measurements. Frequency‐dependent parametric relations were obtained using a linear least‐squares regression. The results are useful to better fine‐tune the storage and loss moduli of HA‐Ge hydrogels by varying the concentrations of the constituents for use in patient‐specific treatments. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 283–290, 2016.